23andMe Goes Global In Its Data-Mining Efforts
By Megan Molteni,
Wired
| 05. 18. 2018
Yanny or Laurel—could the secret to which word you hear be in your DNA? It’s a notion someone pitched at 23andMe headquarters Thursday, during the consumer genetics outfit’s annual Genome Research Day. (Spoiler: The company is not going to roll out a survey to see if the latest meme has a genetic component.)
The event—a sort of cross between a science fair and a recruiting booth—attracted more than 100 researchers to the company’s candy cane–colored lunchroom for a day of talks, poster presentations, and most importantly, information sessions about how to work with 23andMe’s consumer data riches.
23andMe has amassed more than 4 million genetic profiles from customers who’ve consented to be studied, one of the biggest genetic research resources in the US. And because most of those people fill out lots of surveys, each genetic profile comes attached to about 300 phenotypic data points—like how many cigarettes you’ve smoked during your lifetime or if anyone in your family has ever been diagnosed with mild cognitive impairment.
And while the company has doubled in size over the last two years...
Related Articles
By Editorial Staff, The Guardian | 07.05.2026
Ever since Crispr-Cas9 gene-editing technology emerged in the early 2010s, ethical questions around genetically altered humans, so-called designer babies, have become increasingly urgent. There is already a worldwide legal prohibition. No country currently allows human germline editing (meaning genetic changes...
By Sarah Norcross, Sandy Starr, Amanda Cooney, and Anneliese Burton, BioNews | 07.06.2026
By Anna Louie Sussman, The New York Times | 07.01.2026
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers of fertility: ultrawealthy men. Deploying nearly limitless resources, a small number of them are reproducing at such an extraordinary scale...
By Emily Baumgaertner Nunn, The New York Times | 06.11.2026
When scientists at Columbia University announced they had used a newer technology to precisely edit the genes of human embryos last week, they set the academic community ablaze with debate. Is this good news or bad? How fast will...